These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18644422)

  • 21. Increased levels of plasma brain-derived neurotrophic factor (BDNF) in children with attention deficit-hyperactivity disorder (ADHD).
    Shim SH; Hwangbo Y; Kwon YJ; Jeong HY; Lee BH; Lee HJ; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1824-8. PubMed ID: 18760321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late-onset ADHD in adults: milder, but still dysfunctional.
    Karam RG; Bau CH; Salgado CA; Kalil KL; Victor MM; Sousa NO; Vitola ES; Picon FA; Zeni GD; Rohde LA; Belmonte-de-Abreu P; Grevet EH
    J Psychiatr Res; 2009 Apr; 43(7):697-701. PubMed ID: 19007940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder.
    Adler LA; Liebowitz M; Kronenberger W; Qiao M; Rubin R; Hollandbeck M; Deldar A; Schuh K; Durell T
    Depress Anxiety; 2009; 26(3):212-21. PubMed ID: 19194995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bipolar disorders and quality of life: the impact of attention deficit/hyperactivity disorder and substance abuse in euthymic patients.
    Sentissi O; Navarro JC; De Oliveira H; Gourion D; Bourdel MC; Baylé FJ; Olié JP; Poirier MF
    Psychiatry Res; 2008 Oct; 161(1):36-42. PubMed ID: 18786727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in oxidative stress and cellular immunity serum markers in attention-deficit/hyperactivity disorder.
    Ceylan MF; Sener S; Bayraktar AC; Kavutcu M
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):220-6. PubMed ID: 22443244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low blood levels of lead and mercury and symptoms of attention deficit hyperactivity in children: a report of the children's health and environment research (CHEER).
    Ha M; Kwon HJ; Lim MH; Jee YK; Hong YC; Leem JH; Sakong J; Bae JM; Hong SJ; Roh YM; Jo SJ
    Neurotoxicology; 2009 Jan; 30(1):31-6. PubMed ID: 19100765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treating adult attention deficit hyperactivity disorder in hospitalized psychiatric patients.
    Castaneda R; Levy R; Hazzi C; Ross S; Roman W; Hamid H
    Gen Hosp Psychiatry; 2008; 30(6):572-7. PubMed ID: 19061685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative imbalance in obsessive compulsive disorder patients: a total evaluation of oxidant-antioxidant status.
    Selek S; Herken H; Bulut M; Ceylan MF; Celik H; Savas HA; Erel O
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):487-91. PubMed ID: 18006203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of a scale to assess the symptoms of attention-deficit/hyperactivity disorder in young adults.
    Caterino LC; Gómez-Benito J; Balluerka N; Amador-Campos JA; Stock WA
    Psychol Assess; 2009 Jun; 21(2):152-61. PubMed ID: 19485670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet serotonin concentration in children with attention-deficit/hyperactivity disorder.
    Hercigonja Novkovic V; Rudan V; Pivac N; Nedic G; Muck-Seler D
    Neuropsychobiology; 2009; 59(1):17-22. PubMed ID: 19221444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antioxidant capacity and nitric oxide in patients with hepatic cirrhosis.
    Koruk M; Aksoy H; Akçay F; Onuk MD
    Ann Clin Lab Sci; 2002; 32(3):252-6. PubMed ID: 12175087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A psycho-genetic study of associations between the symptoms of binge eating disorder and those of attention deficit (hyperactivity) disorder.
    Davis C; Patte K; Levitan RD; Carter J; Kaplan AS; Zai C; Reid C; Curtis C; Kennedy JL
    J Psychiatr Res; 2009 Apr; 43(7):687-96. PubMed ID: 19041097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma nitric oxide, endothelin-1, arginase and superoxide dismutase in pre-eclamptic women.
    Bernardi F; Constantino L; Machado R; Petronilho F; Dal-Pizzol F
    J Obstet Gynaecol Res; 2008 Dec; 34(6):957-63. PubMed ID: 19012693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ADHD in adult psychiatry. Minimum rates and clinical presentation in general psychiatry outpatients.
    Nylander L; Holmqvist M; Gustafson L; Gillberg C
    Nord J Psychiatry; 2009; 63(1):64-71. PubMed ID: 18991159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome.
    Kuşçu NK; Var A
    Acta Obstet Gynecol Scand; 2009; 88(5):612-7. PubMed ID: 19308750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unwanted intrusive and worrisome thoughts in adults with Attention Deficit\Hyperactivity Disorder.
    Abramovitch A; Schweiger A
    Psychiatry Res; 2009 Aug; 168(3):230-3. PubMed ID: 19570581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case-control study on family environment related factors in attention deficit hyperactivity disorder with anxiety disorder].
    Zhang YB; Luo XR; Liu X; Wei Z; Guan BQ; Yuan XH; Ye HS; Ning ZJ; Yang W; Ding J; Deng YL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):119-22. PubMed ID: 19565868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans.
    Reif A; Jacob CP; Rujescu D; Herterich S; Lang S; Gutknecht L; Baehne CG; Strobel A; Freitag CM; Giegling I; Romanos M; Hartmann A; Rösler M; Renner TJ; Fallgatter AJ; Retz W; Ehlis AC; Lesch KP
    Arch Gen Psychiatry; 2009 Jan; 66(1):41-50. PubMed ID: 19124687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Validation of the Spanish version of the attention deficit hyperactivity disorder adult screening scale (ASRS v. 1.1): a novel scoring strategy].
    Ramos-Quiroga JA; Daigre C; Valero S; Bosch R; Gómez-Barros N; Nogueira M; Palomar G; Roncero C; Casas M
    Rev Neurol; 2009 May 1-15; 48(9):449-52. PubMed ID: 19396760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Attention deficit hyperactivity behavioral phenotype dimensions of adults from Antioquian families using the Wender-Utah Scale -Spanish version].
    Trujillo-Orrego N; Pineda DA; Arango CP; Puerta IC; Lopera F; Aguirre-Acevedo DC; Hincapie-Henao L; Pineda-Alvarez DE; Arcos-Burgos M; Muenke M
    Rev Neurol; 2009 Apr 16-30; 48(8):400-6. PubMed ID: 19340779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.